Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice

BACKGROUND: Miglitol is an oral anti-diabetic drug that acts by inhibiting carbohydrate absorption in the small intestine. Recent studies have shown that miglitol reduces obesity in humans and rodents. However, its mechanisms have remained unclear. The purpose of this study was to determine whether...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sugimoto, Satoru, Nakajima, Hisakazu, Kodo, Kazuki, Mori, Jun, Matsuo, Kensuke, Kosaka, Kitaro, Aoi, Wataru, Yoshimoto, Kanji, Ikegaya, Hiroshi, Hosoi, Hajime
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986880/
https://ncbi.nlm.nih.gov/pubmed/24669882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-7075-11-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados